Exchange Traded Concepts’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
73,142
+2,307
+3% +$52.5K 0.01% 741
2026
Q1
$1.52M Sell
70,835
-6,272
-8% -$131K 0.01% 673
2025
Q4
$1.65M Buy
77,107
+6,276
+9% +$129K 0.01% 635
2025
Q3
$1.19M Buy
+70,831
New +$1.06M 0.01% 713
2024
Q3
– Sell
-42,700
Closed -$322K – 1391
2024
Q2
$322K Buy
42,700
+5,660
+15% +$46.8K 0.01% 815
2024
Q1
$372K Sell
37,040
-6,328
-15% -$58.9K 0.01% 709
2023
Q4
$403K Buy
43,368
+13,194
+44% +$136K 0.01% 693
2023
Q3
$384K Sell
30,174
-1,311
-4% -$18K 0.01% 680
2023
Q2
$447K Buy
31,485
+6,018
+24% +$84.5K 0.01% 636
2023
Q1
$380K Buy
+25,467
New +$386K 0.01% 635

Other funds holding MD

Exchange Traded Concepts's MD Position: Q2 2026 in Review

Exchange Traded Concepts increased its Pediatrix Medical (MD) stake by 3.3% in Q2 2026, buying an estimated $52.5K and bringing the position to 73,142 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #741.

Exchange Traded Concepts first reported a position in MD in Q1 2023 and has held it in 10 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Exchange Traded Concepts held 73,142 shares of Pediatrix Medical worth $1.85M as of Q2 2026.
  • Exchange Traded Concepts bought 2,307 Pediatrix Medical shares in Q2 2026, an estimated $52.5K.
  • Pediatrix Medical made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #741 holding.
  • Exchange Traded Concepts first reported a position in Pediatrix Medical in Q1 2023 and has held it in 10 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.